What is the difference between dermocosmetics and cosmetics?
The real difference is not legal status but formulation approach, active levels and the burden of evidence.
Updated:
Short answer
Dermocosmetics and cosmetics fall under the same regulation; “dermocosmetic” is not a separate legal category. The difference is in practice: dermocosmetic products target a specific skin concern with higher, efficacy-supported active levels, are usually sold through pharmacy and clinical channels, and are expected to support their claims with test data.
Is there a legal difference?
No. In Türkiye and the European Union, “dermocosmetic” is not a separate legal category; both groups fall under cosmetics regulation. Printing “dermocosmetic” on a pack confers no additional legal status.
This distinction matters: a dermocosmetic product is not a medicine and cannot claim to treat disease. If it does, the product falls under medicines regulation and an entirely different approval process.
Where the real difference lies
The difference is in formulation approach and the burden of evidence. A general moisturiser aims to hydrate; a dermocosmetic serum targets a specific concern — pigmentation, acne, barrier damage, signs of ageing — and does so through a particular active.
That targeting makes formulation harder. The active must be used at a level where it works, remain tolerable, and stay stable across shelf life. Meeting all three at once is an engineering problem.
Active level and stability
In dermocosmetics, active concentration alone is not a meaningful indicator. A high but oxidised vitamin C does less than a lower but properly stabilised one.
Carrier system, pH and protective packaging decisions therefore matter as much as concentration. Selling a retinol product in a clear pump bottle is a technical error.
Channel and expectation
Dermocosmetics sell mainly through pharmacies, dermatology clinics and specialist channels. Those channels routinely require technical documents from suppliers — product safety report, certificate of analysis, ingredient list.
Consumer expectations differ too: someone buying dermocosmetics usually reads the ingredient list, asks about active levels and expects to see an effect within a defined period. Communication must therefore be more concrete and more defensible.
Balancing claim against evidence
Regulation does not require efficacy testing for every product — the safety assessment is what is mandatory. But if your product carries a specific efficacy claim — say “visible reduction in pigmentation in four weeks” — that claim must be supported by data.
The practical approach: decide which claim you want to carry at the outset, find out which test it requires, and plan the testing budget accordingly. Adding a claim later always costs more than planning the test from the start.